| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |